Updated to 17,446 COVID-19 WGS from GISAID.
Table 1. Results from PSET analysis. The five Noblis assays were compared alongside the four assays from Corman and three assays from the CDC. Along with assays from China, Hong Kong, Thailand, Japan, and France. Each assay was tested using SARS-CoV-2 as the intended target. All off-target hits (TN, PF, FP) are to entries in NCBI BLAST databases (nt, gss, and env_nt).
identifier |
type |
targets |
PT |
TP |
FN |
Percent True |
PF |
FP |
TN |
Noblis.12 |
Probe |
2697049 |
17251 |
81 |
114 |
99.35% |
0 |
0 |
680 |
Noblis.40 |
Probe |
2697049 |
16740 |
627 |
79 |
99.55% |
0 |
1 |
1420 |
Noblis.42 |
Probe |
2697049 |
17338 |
33 |
75 |
99.57% |
0 |
2 |
1136 |
Noblis.44 |
Probe |
2697049 |
17127 |
48 |
271 |
98.45% |
0 |
1 |
1786 |
Noblis.57 |
Probe |
2697049 |
17153 |
137 |
156 |
99.11% |
0 |
1 |
853 |
ncov_e_gene |
Probe |
2697049 |
17297 |
50 |
99 |
99.43% |
361 |
15 |
53 |
ncov_n_gene |
Probe |
2697049 |
17199 |
143 |
104 |
99.40% |
0 |
340 |
72 |
ncov_rdrp_1 |
Probe |
2697049 |
0 |
17392 |
54 |
99.69% |
433 |
105 |
5967 |
ncov_rdrp_2 |
Probe |
2697049 |
2 |
17389 |
55 |
99.68% |
2 |
73 |
5916 |
cdc_n1 |
Probe |
2697049 |
16952 |
443 |
51 |
99.71% |
0 |
2 |
381 |
cdc_n2 |
Probe |
2697049 |
16939 |
137 |
370 |
97.88% |
0 |
1 |
372 |
cdc_n3 |
Probe |
2697049 |
17038 |
361 |
47 |
99.73% |
1 |
353 |
36 |
China_N |
Probe |
2697049 |
13895 |
241 |
3310 |
81.03% |
0 |
2 |
691 |
China_ORF1ab |
Probe |
2697049 |
16202 |
147 |
1097 |
93.71% |
1 |
0 |
367 |
France_nCoV_IP2 |
Probe |
2697049 |
17301 |
69 |
76 |
99.56% |
1 |
0 |
367 |
France_nCoV_IP4 |
Probe |
2697049 |
17308 |
75 |
63 |
99.64% |
0 |
0 |
1190 |
HKU-N |
Probe |
2697049 |
16938 |
145 |
363 |
97.92% |
327 |
33 |
34 |
HKU-ORF1b-nsp14 |
Probe |
2697049 |
17287 |
83 |
76 |
99.56% |
324 |
29 |
452 |
Japan_NIID_2019-nCOV_N |
Probe |
2697049 |
0 |
17076 |
370 |
97.88% |
0 |
0 |
384 |
Japan_NIID_WH-1_F24381 |
Outer |
2697049 |
17178 |
165 |
103 |
99.41% |
0 |
1 |
601 |
Japan_NIID_WH-1_F501 |
Outer |
2697049 |
16964 |
318 |
164 |
99.06% |
0 |
1 |
370 |
Japan_NIID_WH-1_F509 |
Outer |
2697049 |
17110 |
163 |
173 |
99.01% |
1 |
0 |
369 |
Japan_NIID_WH-1_Seq_F24383 |
Outer |
2697049 |
17172 |
165 |
109 |
99.38% |
0 |
0 |
606 |
Japan_NIID_WH-1_Seq_F519 |
Outer |
2697049 |
16948 |
253 |
245 |
98.60% |
0 |
1 |
369 |
Japan_WuhanCoV-spk1 |
Outer |
2697049 |
17208 |
133 |
105 |
99.40% |
1 |
1 |
594 |
Thailand_WH-NIC_N |
Probe |
2697049 |
17216 |
173 |
57 |
99.67% |
0 |
2 |
375 |
*Updated to 25,181 COVID-19 WGS from GISAID. (*small error in previous post, re-uploaded with correction)
Table 1. Results from PSET analysis. The five Noblis assays were compared alongside the four assays from Corman and three assays from the CDC. Along with assays from China, Hong Kong, Thailand, Japan, and France. Each assay was tested using SARS-CoV-2 as the intended target. All off-target hits (TN, PF, FP) are to entries in NCBI BLAST databases (nt, gss, and env_nt).
identifier |
type |
PT |
TP |
FN |
Percent True |
PF |
FP |
TN |
Noblis.12 |
Probe |
24952 |
107 |
122 |
99.52% |
0 |
0 |
680 |
Noblis.40 |
Probe |
24227 |
871 |
83 |
99.67% |
0 |
1 |
1420 |
Noblis.42 |
Probe |
25011 |
43 |
127 |
99.50% |
0 |
2 |
1136 |
Noblis.44 |
Probe |
24681 |
75 |
425 |
98.31% |
0 |
1 |
1786 |
Noblis.57 |
Probe |
24777 |
210 |
194 |
99.23% |
0 |
1 |
853 |
ncov_e_gene |
Probe |
25005 |
68 |
108 |
99.57% |
361 |
15 |
53 |
ncov_n_gene |
Probe |
24847 |
214 |
120 |
99.52% |
0 |
340 |
72 |
ncov_rdrp_1 |
Probe |
0 |
25122 |
59 |
99.77% |
433 |
105 |
5967 |
ncov_rdrp_2 |
Probe |
2 |
25119 |
60 |
99.76% |
2 |
73 |
5916 |
cdc_n1 |
Probe |
24582 |
533 |
66 |
99.74% |
0 |
2 |
381 |
cdc_n2 |
Probe |
24617 |
181 |
383 |
98.48% |
0 |
1 |
372 |
cdc_n3 |
Probe |
24675 |
399 |
107 |
99.58% |
1 |
353 |
36 |
China_N |
Probe |
18633 |
320 |
6228 |
75.27% |
0 |
2 |
691 |
China_ORF1ab |
Probe |
23801 |
150 |
1230 |
95.12% |
1 |
0 |
367 |
France_nCoV_IP2 |
Probe |
24984 |
106 |
91 |
99.64% |
1 |
0 |
367 |
France_nCoV_IP4 |
Probe |
24927 |
180 |
74 |
99.71% |
0 |
0 |
1190 |
HKU-N |
Probe |
24627 |
179 |
375 |
98.51% |
327 |
33 |
34 |
HKU-ORF1b-nsp14 |
Probe |
24942 |
145 |
94 |
99.63% |
324 |
29 |
452 |
Japan_NIID_2019-nCOV_N |
Probe |
0 |
24797 |
384 |
98.48% |
0 |
0 |
384 |
Japan_NIID_WH-1_F24381 |
Outer |
24762 |
291 |
128 |
99.49% |
0 |
1 |
601 |
Japan_NIID_WH-1_F501 |
Outer |
24614 |
388 |
179 |
99.29% |
0 |
1 |
370 |
Japan_NIID_WH-1_F509 |
Outer |
24767 |
227 |
187 |
99.26% |
1 |
0 |
369 |
Japan_NIID_WH-1_Seq_F24383 |
Outer |
24757 |
291 |
133 |
99.47% |
0 |
0 |
606 |
Japan_NIID_WH-1_Seq_F519 |
Outer |
24591 |
298 |
292 |
98.84% |
0 |
1 |
369 |
Japan_WuhanCoV-spk1 |
Outer |
24792 |
259 |
130 |
99.48% |
1 |
1 |
594 |
Thailand_WH-NIC_N |
Probe |
24878 |
232 |
71 |
99.72% |
0 |
2 |
375 |
Updated to 30,561 COVID-19 WGS from GISAID.
Table 1. Results from PSET analysis. The five Noblis assays were compared alongside the four assays from Corman and three assays from the CDC. Along with assays from China, Hong Kong, Thailand, Japan, and France. Each assay was tested using SARS-CoV-2 as the intended target. All off-target hits (TN, PF, FP) are to entries in NCBI BLAST databases (nt, gss, and env_nt).
identifier |
type |
PT |
TP |
FN |
Percent True |
PF |
FP |
TN |
Noblis.12 |
Probe |
30281 |
139 |
141 |
99.54% |
0 |
0 |
680 |
Noblis.40 |
Probe |
29454 |
1013 |
94 |
99.69% |
0 |
1 |
1420 |
Noblis.42 |
Probe |
30352 |
60 |
149 |
99.51% |
0 |
2 |
1136 |
Noblis.44 |
Probe |
30013 |
95 |
453 |
98.52% |
0 |
1 |
1786 |
Noblis.57 |
Probe |
30033 |
267 |
261 |
99.15% |
0 |
1 |
853 |
ncov_e_gene |
Probe |
30355 |
81 |
125 |
99.59% |
361 |
15 |
53 |
ncov_n_gene |
Probe |
30153 |
266 |
142 |
99.54% |
0 |
340 |
72 |
ncov_rdrp_1 |
Probe |
0 |
30483 |
78 |
99.74% |
433 |
105 |
5967 |
ncov_rdrp_2 |
Probe |
2 |
30483 |
76 |
99.75% |
2 |
73 |
5916 |
cdc_n1 |
Probe |
29815 |
664 |
82 |
99.73% |
0 |
2 |
381 |
cdc_n2 |
Probe |
29912 |
249 |
400 |
98.69% |
0 |
1 |
372 |
cdc_n3 |
Probe |
29996 |
497 |
68 |
99.78% |
1 |
353 |
36 |
China_N |
Probe |
22004 |
375 |
8182 |
73.23% |
0 |
2 |
691 |
China_ORF1ab |
Probe |
28846 |
183 |
1532 |
94.99% |
1 |
0 |
367 |
France_nCoV_IP2 |
Probe |
30343 |
122 |
96 |
99.69% |
1 |
0 |
367 |
France_nCoV_IP4 |
Probe |
30271 |
208 |
82 |
99.73% |
0 |
0 |
1190 |
HKU-N |
Probe |
29953 |
218 |
390 |
98.72% |
327 |
33 |
34 |
HKU-ORF1b-nsp14 |
Probe |
30247 |
209 |
105 |
99.66% |
324 |
29 |
452 |
Japan_NIID_2019-nCOV_N |
Probe |
0 |
30160 |
401 |
98.69% |
0 |
0 |
384 |
Japan_NIID_WH-1_F24381 |
Outer |
30007 |
394 |
160 |
99.48% |
0 |
1 |
601 |
Japan_NIID_WH-1_F501 |
Outer |
29912 |
437 |
212 |
99.31% |
0 |
1 |
370 |
Japan_NIID_WH-1_F509 |
Outer |
30075 |
265 |
221 |
99.28% |
1 |
0 |
369 |
Japan_NIID_WH-1_Seq_F24383 |
Outer |
30002 |
391 |
168 |
99.45% |
0 |
0 |
606 |
Japan_NIID_WH-1_Seq_F519 |
Outer |
29898 |
320 |
343 |
98.88% |
0 |
1 |
369 |
Japan_WuhanCoV-spk1 |
Outer |
30039 |
352 |
170 |
99.44% |
1 |
1 |
594 |
Thailand_WH-NIC_N |
Probe |
30203 |
273 |
85 |
99.72% |
0 |
2 |
375 |
Updated to 34,646 COVID-19 WGS from GISAID.
Table 1. Results from PSET analysis. The five Noblis assays were compared alongside the four assays from Corman and three assays from the CDC. Along with assays from China, Hong Kong, Thailand, Japan, and France. Each assay was tested using SARS-CoV-2 as the intended target. All off-target hits (TN, PF, FP) are to entries in NCBI BLAST databases (nt and env_nt).
identifier |
type |
PT |
TP |
FN |
Percent True |
PF |
FP |
TN |
Noblis.12 |
Probe |
34345 |
148 |
153 |
99.56% |
0 |
0 |
680 |
Noblis.40 |
Probe |
33477 |
1073 |
96 |
99.72% |
0 |
1 |
1420 |
Noblis.42 |
Probe |
34424 |
66 |
156 |
99.55% |
0 |
2 |
1136 |
Noblis.44 |
Probe |
34059 |
119 |
468 |
98.65% |
0 |
1 |
1786 |
Noblis.57 |
Probe |
34064 |
301 |
281 |
99.19% |
0 |
1 |
853 |
ncov_e_gene |
Probe |
34379 |
93 |
174 |
99.50% |
361 |
15 |
53 |
ncov_n_gene |
Probe |
34175 |
297 |
174 |
99.50% |
0 |
340 |
72 |
ncov_rdrp_1 |
Probe |
0 |
34563 |
83 |
99.76% |
433 |
105 |
5967 |
ncov_rdrp_2 |
Probe |
2 |
34563 |
81 |
99.77% |
2 |
73 |
5916 |
cdc_n1 |
Probe |
33786 |
770 |
90 |
99.74% |
0 |
2 |
381 |
cdc_n2 |
Probe |
33957 |
272 |
417 |
98.80% |
0 |
1 |
372 |
cdc_n3 |
Probe |
33981 |
536 |
129 |
99.63% |
1 |
353 |
36 |
China_N |
Probe |
24954 |
415 |
9277 |
73.22% |
0 |
2 |
691 |
China_ORF1ab |
Probe |
32864 |
172 |
1610 |
95.35% |
1 |
0 |
367 |
France_nCoV_IP2 |
Probe |
34392 |
140 |
114 |
99.67% |
1 |
0 |
367 |
France_nCoV_IP4 |
Probe |
34327 |
233 |
86 |
99.75% |
0 |
0 |
1190 |
HKU-N |
Probe |
33992 |
247 |
407 |
98.83% |
327 |
33 |
34 |
HKU-ORF1b-nsp14 |
Probe |
34317 |
213 |
116 |
99.67% |
324 |
29 |
452 |
Japan_NIID_2019-nCOV_N |
Probe |
0 |
34217 |
429 |
98.76% |
0 |
0 |
384 |
Japan_NIID_WH-1_F24381 |
Outer |
34037 |
429 |
180 |
99.48% |
0 |
1 |
601 |
Japan_NIID_WH-1_F501 |
Outer |
33845 |
560 |
241 |
99.30% |
0 |
1 |
370 |
Japan_NIID_WH-1_F509 |
Outer |
34042 |
301 |
303 |
99.13% |
1 |
0 |
369 |
Japan_NIID_WH-1_Seq_F24383 |
Outer |
34028 |
429 |
189 |
99.45% |
0 |
0 |
606 |
Japan_NIID_WH-1_Seq_F519 |
Outer |
33835 |
371 |
440 |
98.73% |
0 |
1 |
369 |
Japan_WuhanCoV-spk1 |
Outer |
34079 |
380 |
187 |
99.46% |
1 |
1 |
594 |
Thailand_WH-NIC_N |
Probe |
34261 |
289 |
96 |
99.72% |
0 |
2 |
375 |
Updated to 39,051 COVID-19 WGS from GISAID.
Table 1. Results from PSET analysis. The five Noblis assays were compared alongside the four assays from Corman and three assays from the CDC. Along with assays from China, Hong Kong, Thailand, Japan, and France. Each assay was tested using SARS-CoV-2 as the intended target. All off-target hits (TN, PF, FP) are to entries in NCBI BLAST databases (nt and env_nt).
identifier |
type |
PT |
TP |
FN |
Percent True |
PF |
FP |
TN |
Noblis.12 |
Probe |
38711 |
176 |
164 |
99.58% |
0 |
0 |
680 |
Noblis.40 |
Probe |
37741 |
1210 |
100 |
99.74% |
0 |
1 |
1420 |
Noblis.42 |
Probe |
38796 |
77 |
178 |
99.54% |
0 |
2 |
1136 |
Noblis.44 |
Probe |
38391 |
158 |
502 |
98.71% |
0 |
1 |
1786 |
Noblis.57 |
Probe |
38355 |
381 |
315 |
99.19% |
0 |
1 |
853 |
ncov_e_gene |
Probe |
38740 |
118 |
193 |
99.51% |
361 |
15 |
53 |
ncov_n_gene |
Probe |
38441 |
400 |
210 |
99.46% |
0 |
340 |
72 |
ncov_rdrp_1 |
Probe |
0 |
38960 |
91 |
99.77% |
433 |
105 |
5967 |
ncov_rdrp_2 |
Probe |
2 |
38960 |
89 |
99.77% |
2 |
73 |
5916 |
cdc_n1 |
Probe |
37989 |
958 |
104 |
99.73% |
0 |
2 |
381 |
cdc_n2 |
Probe |
38168 |
308 |
575 |
98.53% |
0 |
1 |
372 |
cdc_n3 |
Probe |
38297 |
611 |
143 |
99.63% |
1 |
353 |
36 |
China_N |
Probe |
27528 |
485 |
11038 |
71.73% |
0 |
2 |
691 |
China_ORF1ab |
Probe |
37074 |
248 |
1729 |
95.57% |
1 |
0 |
367 |
France_nCoV_IP2 |
Probe |
38748 |
177 |
126 |
99.68% |
1 |
0 |
367 |
France_nCoV_IP4 |
Probe |
38713 |
249 |
89 |
99.77% |
0 |
0 |
1190 |
HKU-N |
Probe |
38159 |
325 |
567 |
98.55% |
327 |
33 |
34 |
HKU-ORF1b-nsp14 |
Probe |
38696 |
232 |
123 |
99.69% |
324 |
29 |
452 |
Japan_NIID_2019-nCOV_N |
Probe |
0 |
38461 |
590 |
98.49% |
0 |
0 |
384 |
Japan_NIID_WH-1_F24381 |
Outer |
38357 |
475 |
219 |
99.44% |
0 |
1 |
601 |
Japan_NIID_WH-1_F501 |
Outer |
38119 |
662 |
270 |
99.31% |
0 |
1 |
370 |
Japan_NIID_WH-1_F509 |
Outer |
38376 |
330 |
345 |
99.12% |
1 |
0 |
369 |
Japan_NIID_WH-1_Seq_F24383 |
Outer |
38347 |
475 |
229 |
99.41% |
0 |
0 |
606 |
Japan_NIID_WH-1_Seq_F519 |
Outer |
38137 |
401 |
513 |
98.69% |
0 |
1 |
369 |
Japan_WuhanCoV-spk1 |
Outer |
38403 |
422 |
226 |
99.42% |
1 |
1 |
594 |
Thailand_WH-NIC_N |
Probe |
38585 |
356 |
110 |
99.72% |
0 |
2 |
375 |
Updated to 45,665 COVID-19 WGS from GISAID.
Table 1. Results from PSET analysis. The five Noblis assays were compared alongside the four assays from Corman and three assays from the CDC. Along with assays from China, Hong Kong, Thailand, Japan, France, South Korea, and Singapore. 12 New assays added. Each assay was tested using SARS-CoV-2 as the intended target. All off-target hits (TN, PF, FP) are to entries in NCBI BLAST databases (nt and env_nt).
identifier |
type |
PT |
TP |
FN |
Percent True |
PF |
FP |
TN |
Noblis.12 |
Probe |
45257 |
202 |
206 |
99.55% |
0 |
0 |
680 |
Noblis.40 |
Probe |
44122 |
1407 |
136 |
99.70% |
0 |
1 |
1420 |
Noblis.42 |
Probe |
45350 |
94 |
221 |
99.52% |
0 |
2 |
1136 |
Noblis.44 |
Probe |
44905 |
199 |
561 |
98.77% |
0 |
1 |
1786 |
Noblis.57 |
Probe |
44845 |
431 |
389 |
99.15% |
0 |
1 |
853 |
ncov_e_gene |
Probe |
45272 |
145 |
248 |
99.46% |
361 |
15 |
53 |
ncov_n_gene |
Probe |
44916 |
486 |
263 |
99.42% |
0 |
340 |
72 |
ncov_rdrp_1 |
Probe |
0 |
45528 |
137 |
99.70% |
433 |
105 |
5967 |
ncov_rdrp_2 |
Probe |
2 |
45531 |
132 |
99.71% |
2 |
73 |
5916 |
cdc_n1 |
Probe |
44356 |
1190 |
119 |
99.74% |
0 |
2 |
381 |
cdc_n2 |
Probe |
44682 |
352 |
631 |
98.62% |
0 |
1 |
372 |
cdc_n3 |
Probe |
44786 |
715 |
164 |
99.64% |
1 |
353 |
36 |
China_N |
Probe |
32237 |
557 |
12871 |
71.81% |
0 |
2 |
691 |
China_ORF1ab |
Probe |
43473 |
372 |
1820 |
96.01% |
1 |
0 |
367 |
France_nCoV_IP2 |
Probe |
45322 |
196 |
147 |
99.68% |
1 |
0 |
367 |
France_nCoV_IP4 |
Probe |
45289 |
275 |
101 |
99.78% |
0 |
0 |
1190 |
HKU-N |
Probe |
44664 |
374 |
627 |
98.63% |
327 |
33 |
34 |
HKU-ORF1b-nsp14 |
Probe |
45224 |
288 |
153 |
99.66% |
324 |
29 |
452 |
Japan_NIID_2019-nCOV_N |
Probe |
0 |
45011 |
654 |
98.57% |
0 |
0 |
384 |
Japan_NIID_WH-1_F24381 |
Outer |
44867 |
540 |
258 |
99.44% |
0 |
1 |
601 |
Japan_NIID_WH-1_F501 |
Outer |
44660 |
699 |
306 |
99.33% |
0 |
1 |
370 |
Japan_NIID_WH-1_F509 |
Outer |
44875 |
401 |
389 |
99.15% |
1 |
0 |
369 |
Japan_NIID_WH-1_Seq_F24383 |
Outer |
44855 |
542 |
268 |
99.41% |
0 |
0 |
606 |
Japan_NIID_WH-1_Seq_F519 |
Outer |
44561 |
492 |
612 |
98.66% |
0 |
1 |
369 |
Japan_WuhanCoV-spk1 |
Outer |
44931 |
466 |
268 |
99.41% |
1 |
1 |
594 |
Thailand_WH-NIC_N |
Probe |
45043 |
494 |
128 |
99.72% |
0 |
2 |
375 |
Chan-N |
Probe |
44758 |
282 |
625 |
98.63% |
4 |
3 |
353 |
Chan-ORF1ab |
Probe |
0 |
45266 |
399 |
99.13% |
0 |
5 |
2 |
Chan-S |
Probe |
44678 |
158 |
829 |
98.18% |
5 |
0 |
2 |
Niu-E |
Probe |
45162 |
223 |
280 |
99.39% |
26 |
359 |
0 |
Won-E |
Outer |
2 |
45443 |
220 |
99.52% |
0 |
384 |
1 |
Won-N |
Outer |
44620 |
827 |
218 |
99.52% |
8 |
7 |
358 |
Won-ORF1ab |
Outer |
45260 |
242 |
163 |
99.64% |
5 |
2 |
313 |
Won-S |
Outer |
43872 |
154 |
1639 |
96.41% |
5 |
1 |
0 |
Yip-ORF1ab |
Outer |
45075 |
141 |
449 |
99.02% |
5 |
1 |
1 |
Young-N |
Probe |
0 |
45433 |
232 |
99.49% |
0 |
5 |
1 |
Young-ORF1ab |
Probe |
45408 |
150 |
107 |
99.77% |
5 |
1 |
0 |
Young-S |
Probe |
44929 |
374 |
362 |
99.21% |
4 |
1 |
0 |
Updated to 49,073 COVID-19 WGS from GISAID.
Table 1. Results from PSET analysis. The five Noblis assays were compared alongside the four assays from Corman and three assays from the CDC. Along with assays from China, Hong Kong, Thailand, Japan, France, South Korea, and Singapore. Each assay was tested using SARS-CoV-2 as the intended target. All off-target hits (TN, PF, FP) are to entries in NCBI BLAST databases (nt and env_nt).
identifier |
type |
PT |
TP |
FN |
Percent True |
PF |
FP |
TN |
Noblis.12 |
Probe |
48626 |
231 |
216 |
99.56% |
0 |
0 |
680 |
Noblis.40 |
Probe |
47497 |
1438 |
138 |
99.72% |
0 |
1 |
1420 |
Noblis.42 |
Probe |
48706 |
110 |
257 |
99.48% |
0 |
2 |
1136 |
Noblis.44 |
Probe |
48260 |
245 |
568 |
98.84% |
0 |
1 |
1786 |
Noblis.57 |
Probe |
48176 |
494 |
403 |
99.18% |
0 |
1 |
853 |
ncov_e_gene |
Probe |
48666 |
155 |
252 |
99.49% |
361 |
15 |
53 |
ncov_n_gene |
Probe |
48275 |
528 |
270 |
99.45% |
0 |
340 |
72 |
ncov_rdrp_1 |
Probe |
0 |
48932 |
141 |
99.71% |
433 |
105 |
5967 |
ncov_rdrp_2 |
Probe |
2 |
48937 |
134 |
99.73% |
2 |
73 |
5916 |
cdc_n1 |
Probe |
47644 |
1306 |
123 |
99.75% |
0 |
2 |
381 |
cdc_n2 |
Probe |
48037 |
378 |
658 |
98.66% |
0 |
1 |
372 |
cdc_n3 |
Probe |
48149 |
750 |
174 |
99.65% |
1 |
353 |
36 |
China_N |
Probe |
34411 |
599 |
14063 |
71.34% |
0 |
2 |
691 |
China_ORF1ab |
Probe |
46769 |
465 |
1839 |
96.25% |
1 |
0 |
367 |
France_nCoV_IP2 |
Probe |
48702 |
222 |
149 |
99.70% |
1 |
0 |
367 |
France_nCoV_IP4 |
Probe |
48664 |
308 |
101 |
99.79% |
0 |
0 |
1190 |
HKU-N |
Probe |
47944 |
475 |
654 |
98.67% |
327 |
33 |
34 |
HKU-ORF1b-nsp14 |
Probe |
48608 |
304 |
161 |
99.67% |
324 |
29 |
452 |
Japan_NIID_2019-nCOV_N |
Probe |
0 |
48394 |
679 |
98.62% |
0 |
0 |
384 |
Japan_NIID_WH-1_F24381 |
Outer |
48220 |
591 |
262 |
99.47% |
0 |
1 |
601 |
Japan_NIID_WH-1_F501 |
Outer |
48001 |
756 |
316 |
99.36% |
0 |
1 |
370 |
Japan_NIID_WH-1_F509 |
Outer |
48212 |
448 |
413 |
99.16% |
1 |
0 |
369 |
Japan_NIID_WH-1_Seq_F24383 |
Outer |
48209 |
592 |
272 |
99.45% |
0 |
0 |
606 |
Japan_NIID_WH-1_Seq_F519 |
Outer |
47901 |
516 |
656 |
98.66% |
0 |
1 |
369 |
Japan_WuhanCoV-spk1 |
Outer |
48293 |
493 |
287 |
99.42% |
1 |
1 |
594 |
Thailand_WH-NIC_N |
Probe |
48428 |
513 |
132 |
99.73% |
0 |
2 |
375 |
Chan-N |
Probe |
48116 |
302 |
655 |
98.67% |
4 |
3 |
353 |
Chan-ORF1ab |
Probe |
0 |
48594 |
479 |
99.02% |
0 |
5 |
2 |
Chan-S |
Probe |
48050 |
179 |
844 |
98.28% |
5 |
0 |
2 |
Niu-E |
Probe |
48553 |
234 |
286 |
99.42% |
26 |
359 |
0 |
Won-E |
Outer |
2 |
48848 |
223 |
99.55% |
0 |
384 |
1 |
Won-N |
Outer |
47977 |
868 |
228 |
99.54% |
8 |
7 |
358 |
Won-ORF1ab |
Outer |
48630 |
277 |
166 |
99.66% |
5 |
2 |
313 |
Won-S |
Outer |
47016 |
353 |
1704 |
96.53% |
5 |
1 |
0 |
Yip-ORF1ab |
Outer |
48404 |
204 |
465 |
99.05% |
5 |
1 |
1 |
Young-N |
Probe |
0 |
48825 |
248 |
99.49% |
0 |
5 |
1 |
Young-ORF1ab |
Probe |
48811 |
155 |
107 |
99.78% |
5 |
1 |
0 |
Young-S |
Probe |
48298 |
400 |
375 |
99.24% |
4 |
1 |
0 |
Updated to 54,429 COVID-19 WGS from GISAID.
Table 1. Results from PSET analysis. The five Noblis assays were compared alongside the four assays from Corman and three assays from the CDC. Along with assays from China, Hong Kong, Thailand, Japan, France, South Korea, and Singapore. Each assay was tested using SARS-CoV-2 as the intended target. All off-target hits (TN, PF, FP) are to entries in NCBI BLAST databases (nt and env_nt).
identifier |
type |
PT |
TP |
FN |
Percent True |
PF |
FP |
TN |
Noblis.12 |
Probe |
53921 |
230 |
278 |
99.49% |
0 |
0 |
680 |
Noblis.40 |
Probe |
52753 |
1525 |
151 |
99.72% |
0 |
1 |
1420 |
Noblis.42 |
Probe |
54023 |
118 |
288 |
99.47% |
0 |
2 |
1136 |
Noblis.44 |
Probe |
53559 |
260 |
610 |
98.88% |
0 |
1 |
1786 |
Noblis.57 |
Probe |
53411 |
528 |
490 |
99.10% |
0 |
1 |
853 |
ncov_e_gene |
Probe |
53985 |
168 |
276 |
99.49% |
361 |
15 |
53 |
ncov_n_gene |
Probe |
53515 |
597 |
317 |
99.42% |
0 |
340 |
72 |
ncov_rdrp_1 |
Probe |
0 |
54274 |
155 |
99.72% |
433 |
105 |
5967 |
ncov_rdrp_2 |
Probe |
2 |
54283 |
144 |
99.74% |
2 |
73 |
5916 |
cdc_n1 |
Probe |
52801 |
1481 |
147 |
99.73% |
0 |
2 |
381 |
cdc_n2 |
Probe |
53269 |
434 |
726 |
98.67% |
0 |
1 |
372 |
cdc_n3 |
Probe |
53422 |
807 |
200 |
99.63% |
1 |
353 |
36 |
China_N |
Probe |
37416 |
666 |
16347 |
69.97% |
0 |
2 |
691 |
China_ORF1ab |
Probe |
51819 |
432 |
2178 |
96.00% |
1 |
0 |
367 |
France_nCoV_IP2 |
Probe |
54026 |
226 |
177 |
99.67% |
1 |
0 |
367 |
France_nCoV_IP4 |
Probe |
53952 |
366 |
111 |
99.80% |
0 |
0 |
1190 |
HKU-N |
Probe |
53129 |
580 |
720 |
98.68% |
327 |
33 |
34 |
HKU-ORF1b-nsp14 |
Probe |
53922 |
338 |
169 |
99.69% |
324 |
29 |
452 |
Japan_NIID_2019-nCOV_N |
Probe |
0 |
53681 |
748 |
98.63% |
0 |
0 |
384 |
Japan_NIID_WH-1_F24381 |
Outer |
53440 |
689 |
300 |
99.45% |
0 |
1 |
601 |
Japan_NIID_WH-1_F501 |
Outer |
53229 |
822 |
378 |
99.31% |
0 |
1 |
370 |
Japan_NIID_WH-1_F509 |
Outer |
53368 |
597 |
464 |
99.15% |
1 |
0 |
369 |
Japan_NIID_WH-1_Seq_F24383 |
Outer |
53418 |
704 |
307 |
99.44% |
0 |
0 |
606 |
Japan_NIID_WH-1_Seq_F519 |
Outer |
53109 |
576 |
744 |
98.63% |
0 |
1 |
369 |
Japan_WuhanCoV-spk1 |
Outer |
53520 |
602 |
307 |
99.44% |
1 |
1 |
594 |
Thailand_WH-NIC_N |
Probe |
53610 |
661 |
158 |
99.71% |
0 |
2 |
375 |
Chan-N |
Probe |
53373 |
342 |
714 |
98.69% |
4 |
3 |
353 |
Chan-ORF1ab |
Probe |
0 |
53780 |
649 |
98.81% |
0 |
5 |
2 |
Chan-S |
Probe |
53251 |
203 |
975 |
98.21% |
5 |
0 |
2 |
Niu-E |
Probe |
53864 |
257 |
308 |
99.43% |
26 |
359 |
0 |
Won-E |
Outer |
2 |
54183 |
244 |
99.55% |
0 |
384 |
1 |
Won-N |
Outer |
53103 |
1060 |
266 |
99.51% |
8 |
7 |
358 |
Won-ORF1ab |
Outer |
53961 |
263 |
205 |
99.62% |
5 |
2 |
313 |
Won-S |
Outer |
52200 |
179 |
2050 |
96.23% |
5 |
1 |
0 |
Yip-ORF1ab |
Outer |
53597 |
210 |
622 |
98.86% |
5 |
1 |
1 |
Young-N |
Probe |
0 |
54150 |
279 |
99.49% |
0 |
5 |
1 |
Young-ORF1ab |
Probe |
54134 |
179 |
116 |
99.79% |
5 |
1 |
0 |
Young-S |
Probe |
53562 |
464 |
403 |
99.26% |
4 |
1 |
0 |
Updated to 60,164 COVID-19 WGS from GISAID.
Table 1. Results from PSET analysis. The five Noblis assays were compared alongside the four assays from Corman and three assays from the CDC. Along with assays from China, Hong Kong, Thailand, Japan, France, South Korea, and Singapore. Each assay was tested using SARS-CoV-2 as the intended target. All off-target hits (TN, PF, FP) are to entries in NCBI BLAST databases (nt and env_nt).
identifier |
type |
PT |
TP |
FN |
Percent True |
PF |
FP |
TN |
Noblis.12 |
Probe |
59599 |
263 |
302 |
99.50% |
0 |
0 |
680 |
Noblis.40 |
Probe |
58388 |
1604 |
172 |
99.71% |
0 |
1 |
1420 |
Noblis.42 |
Probe |
59712 |
137 |
315 |
99.48% |
0 |
2 |
1136 |
Noblis.44 |
Probe |
59226 |
284 |
654 |
98.91% |
0 |
1 |
1786 |
Noblis.57 |
Probe |
59009 |
577 |
578 |
99.04% |
0 |
1 |
853 |
ncov_e_gene |
Probe |
59629 |
189 |
346 |
99.42% |
361 |
15 |
53 |
ncov_n_gene |
Probe |
59097 |
705 |
362 |
99.40% |
0 |
340 |
72 |
ncov_rdrp_1 |
Probe |
0 |
59967 |
197 |
99.67% |
433 |
105 |
5967 |
ncov_rdrp_2 |
Probe |
4 |
59977 |
183 |
99.70% |
2 |
73 |
5916 |
cdc_n1 |
Probe |
58220 |
1790 |
154 |
99.74% |
0 |
2 |
381 |
cdc_n2 |
Probe |
58905 |
459 |
800 |
98.67% |
0 |
1 |
372 |
cdc_n3 |
Probe |
59068 |
872 |
224 |
99.63% |
1 |
353 |
36 |
China_N |
Probe |
40973 |
742 |
18449 |
69.34% |
0 |
2 |
691 |
China_ORF1ab |
Probe |
57344 |
469 |
2351 |
96.09% |
1 |
0 |
367 |
France_nCoV_IP2 |
Probe |
59690 |
247 |
227 |
99.62% |
1 |
0 |
367 |
France_nCoV_IP4 |
Probe |
59625 |
407 |
132 |
99.78% |
0 |
0 |
1190 |
HKU-N |
Probe |
58744 |
629 |
791 |
98.69% |
327 |
33 |
34 |
HKU-ORF1b-nsp14 |
Probe |
59603 |
363 |
198 |
99.67% |
324 |
29 |
452 |
Japan_NIID_2019-nCOV_N |
Probe |
0 |
59342 |
822 |
98.63% |
0 |
0 |
384 |
Japan_NIID_WH-1_F24381 |
Outer |
58889 |
922 |
353 |
99.41% |
0 |
1 |
601 |
Japan_NIID_WH-1_F501 |
Outer |
58852 |
890 |
422 |
99.30% |
0 |
1 |
370 |
Japan_NIID_WH-1_F509 |
Outer |
58970 |
681 |
513 |
99.15% |
1 |
0 |
369 |
Japan_NIID_WH-1_Seq_F24383 |
Outer |
58862 |
940 |
362 |
99.40% |
0 |
0 |
606 |
Japan_NIID_WH-1_Seq_F519 |
Outer |
58727 |
617 |
820 |
98.64% |
0 |
1 |
369 |
Japan_WuhanCoV-spk1 |
Outer |
58970 |
831 |
363 |
99.40% |
1 |
1 |
594 |
Thailand_WH-NIC_N |
Probe |
59498 |
280 |
386 |
99.36% |
0 |
2 |
375 |
Chan-N |
Probe |
59277 |
722 |
165 |
99.73% |
4 |
3 |
353 |
Chan-ORF1ab |
Probe |
58987 |
388 |
789 |
98.69% |
0 |
5 |
2 |
Chan-S |
Probe |
0 |
59402 |
762 |
98.73% |
5 |
0 |
2 |
Niu-E |
Probe |
58801 |
233 |
1130 |
98.12% |
26 |
359 |
0 |
Won-E |
Outer |
2 |
59852 |
310 |
99.48% |
0 |
384 |
1 |
Won-N |
Outer |
58614 |
1238 |
312 |
99.48% |
8 |
7 |
358 |
Won-ORF1ab |
Outer |
59635 |
283 |
246 |
99.59% |
5 |
2 |
313 |
Won-S |
Outer |
57705 |
202 |
2257 |
96.25% |
5 |
1 |
0 |
Yip-ORF1ab |
Outer |
59189 |
276 |
699 |
98.84% |
5 |
1 |
1 |
Young-N |
Probe |
0 |
59862 |
302 |
99.50% |
0 |
5 |
1 |
Young-ORF1ab |
Probe |
59817 |
203 |
144 |
99.76% |
5 |
1 |
0 |
Young-S |
Probe |
59157 |
558 |
449 |
99.25% |
4 |
1 |
0 |
Updated to 66,862 COVID-19 WGS from GISAID.
Table 1. Results from PSET analysis. The five Noblis assays were compared alongside the four assays from Corman and three assays from the CDC. Along with assays from China, Hong Kong, Thailand, Japan, France, South Korea, and Singapore. Each assay was tested using SARS-CoV-2 as the intended target. All off-target hits (TN, PF, FP) are to entries in NCBI BLAST databases (nt and env_nt).
identifier |
type |
PT |
TP |
FN |
Percent True |
PF |
FP |
TN |
Noblis.12 |
Probe |
66251 |
294 |
317 |
99.53% |
0 |
0 |
680 |
Noblis.40 |
Probe |
64912 |
1767 |
183 |
99.73% |
0 |
1 |
1420 |
Noblis.42 |
Probe |
66354 |
168 |
340 |
99.49% |
0 |
2 |
1136 |
Noblis.44 |
Probe |
65850 |
320 |
692 |
98.97% |
0 |
1 |
1786 |
Noblis.57 |
Probe |
65576 |
649 |
637 |
99.05% |
0 |
1 |
853 |
ncov_e_gene |
Probe |
66264 |
207 |
391 |
99.42% |
361 |
15 |
53 |
ncov_n_gene |
Probe |
65616 |
833 |
413 |
99.38% |
0 |
340 |
72 |
ncov_rdrp_1 |
Probe |
0 |
66649 |
213 |
99.68% |
433 |
105 |
5967 |
ncov_rdrp_2 |
Probe |
4 |
66661 |
197 |
99.71% |
2 |
73 |
5916 |
cdc_n1 |
Probe |
64689 |
2008 |
165 |
99.75% |
0 |
2 |
381 |
cdc_n2 |
Probe |
65479 |
547 |
836 |
98.75% |
0 |
1 |
372 |
cdc_n3 |
Probe |
65653 |
955 |
254 |
99.62% |
1 |
353 |
36 |
China_N |
Probe |
44961 |
938 |
20963 |
68.65% |
0 |
2 |
691 |
China_ORF1ab |
Probe |
63933 |
505 |
2424 |
96.37% |
1 |
0 |
367 |
France_nCoV_IP2 |
Probe |
66352 |
262 |
248 |
99.63% |
1 |
0 |
367 |
France_nCoV_IP4 |
Probe |
66287 |
432 |
143 |
99.79% |
0 |
0 |
1190 |
HKU-N |
Probe |
65338 |
695 |
829 |
98.76% |
327 |
33 |
34 |
HKU-ORF1b-nsp14 |
Probe |
66183 |
465 |
214 |
99.68% |
324 |
29 |
452 |
Japan_NIID_2019-nCOV_N |
Probe |
0 |
65999 |
863 |
98.71% |
0 |
0 |
384 |
Japan_NIID_WH-1_F24381 |
Outer |
65482 |
995 |
385 |
99.42% |
0 |
1 |
601 |
Japan_NIID_WH-1_F501 |
Outer |
65425 |
962 |
475 |
99.29% |
0 |
1 |
370 |
Japan_NIID_WH-1_F509 |
Outer |
65511 |
783 |
568 |
99.15% |
1 |
0 |
369 |
Japan_NIID_WH-1_Seq_F24383 |
Outer |
65455 |
1009 |
398 |
99.40% |
0 |
0 |
606 |
Japan_NIID_WH-1_Seq_F519 |
Outer |
65280 |
665 |
917 |
98.63% |
0 |
1 |
369 |
Japan_WuhanCoV-spk1 |
Outer |
65594 |
873 |
395 |
99.41% |
1 |
1 |
594 |
Thailand_WH-NIC_N |
Probe |
65891 |
793 |
178 |
99.73% |
0 |
2 |
375 |
Chan-N |
Probe |
65579 |
455 |
828 |
98.76% |
4 |
3 |
353 |
Chan-ORF1ab |
Probe |
0 |
66049 |
813 |
98.78% |
0 |
5 |
2 |
Chan-S |
Probe |
65395 |
254 |
1213 |
98.19% |
5 |
0 |
2 |
Niu-E |
Probe |
66120 |
309 |
433 |
99.35% |
26 |
359 |
0 |
Won-E |
Outer |
2 |
66514 |
346 |
99.48% |
0 |
384 |
1 |
Won-N |
Outer |
64929 |
1572 |
361 |
99.46% |
8 |
7 |
358 |
Won-ORF1ab |
Outer |
66276 |
323 |
263 |
99.61% |
5 |
2 |
313 |
Won-S |
Outer |
64167 |
220 |
2475 |
96.30% |
5 |
1 |
0 |
Yip-ORF1ab |
Outer |
65785 |
325 |
752 |
98.88% |
5 |
1 |
1 |
Young-N |
Probe |
0 |
66540 |
322 |
99.52% |
0 |
5 |
1 |
Young-ORF1ab |
Probe |
66479 |
228 |
155 |
99.77% |
5 |
1 |
0 |
Young-S |
Probe |
65727 |
657 |
478 |
99.29% |
4 |
1 |
0 |
Updated to 70,850 COVID-19 WGS from GISAID.
Table 1. Results from PSET analysis. The five Noblis assays were compared alongside the four assays from Corman and three assays from the CDC. Along with assays from China, Hong Kong, Thailand, Japan, France, South Korea, and Singapore. Each assay was tested using SARS-CoV-2 as the intended target. All off-target hits (TN, PF, FP) are to entries in NCBI BLAST databases (nt and env_nt).
identifier |
type |
PT |
TP |
FN |
Percent True |
PF |
FP |
TN |
Noblis.12 |
Probe |
70210 |
313 |
327 |
99.54% |
0 |
0 |
680 |
Noblis.40 |
Probe |
68817 |
1832 |
201 |
99.72% |
0 |
1 |
1420 |
Noblis.42 |
Probe |
70319 |
181 |
350 |
99.51% |
0 |
2 |
1136 |
Noblis.44 |
Probe |
69809 |
339 |
702 |
99.01% |
0 |
1 |
1786 |
Noblis.57 |
Probe |
69430 |
686 |
734 |
98.96% |
0 |
1 |
853 |
ncov_e_gene |
Probe |
70235 |
218 |
397 |
99.44% |
361 |
15 |
53 |
ncov_n_gene |
Probe |
69525 |
865 |
460 |
99.35% |
0 |
340 |
72 |
ncov_rdrp_1 |
Probe |
0 |
70626 |
224 |
99.68% |
433 |
105 |
5967 |
ncov_rdrp_2 |
Probe |
4 |
70639 |
207 |
99.71% |
2 |
73 |
5916 |
cdc_n1 |
Probe |
68548 |
2121 |
181 |
99.74% |
0 |
2 |
381 |
cdc_n2 |
Probe |
69391 |
577 |
882 |
98.76% |
0 |
1 |
372 |
cdc_n3 |
Probe |
69586 |
981 |
283 |
99.60% |
1 |
353 |
36 |
China_N |
Probe |
46971 |
992 |
22887 |
67.70% |
0 |
2 |
691 |
China_ORF1ab |
Probe |
67843 |
529 |
2478 |
96.50% |
1 |
0 |
367 |
France_nCoV_IP2 |
Probe |
70311 |
286 |
253 |
99.64% |
1 |
0 |
367 |
France_nCoV_IP4 |
Probe |
70250 |
453 |
147 |
99.79% |
0 |
0 |
1190 |
HKU-N |
Probe |
69244 |
734 |
872 |
98.77% |
327 |
33 |
34 |
HKU-ORF1b-nsp14 |
Probe |
70118 |
512 |
220 |
99.69% |
324 |
29 |
452 |
Japan_NIID_2019-nCOV_N |
Probe |
0 |
69939 |
911 |
98.71% |
0 |
0 |
384 |
Japan_NIID_WH-1_F24381 |
Outer |
69319 |
1074 |
457 |
99.35% |
0 |
1 |
601 |
Japan_NIID_WH-1_F501 |
Outer |
69317 |
1007 |
526 |
99.26% |
0 |
1 |
370 |
Japan_NIID_WH-1_F509 |
Outer |
69394 |
836 |
620 |
99.12% |
1 |
0 |
369 |
Japan_NIID_WH-1_Seq_F24383 |
Outer |
69289 |
1091 |
470 |
99.34% |
0 |
0 |
606 |
Japan_NIID_WH-1_Seq_F519 |
Outer |
69178 |
690 |
982 |
98.61% |
0 |
1 |
369 |
Japan_WuhanCoV-spk1 |
Outer |
69460 |
921 |
469 |
99.34% |
1 |
1 |
594 |
Thailand_WH-NIC_N |
Probe |
69818 |
829 |
203 |
99.71% |
0 |
2 |
375 |
Chan-N |
Probe |
69487 |
489 |
874 |
98.77% |
4 |
3 |
353 |
Chan-ORF1ab |
Probe |
0 |
70015 |
835 |
98.82% |
0 |
5 |
2 |
Chan-S |
Probe |
69291 |
275 |
1284 |
98.19% |
5 |
0 |
2 |
Niu-E |
Probe |
70086 |
325 |
439 |
99.38% |
26 |
359 |
0 |
Won-E |
Outer |
2 |
70496 |
352 |
99.50% |
0 |
384 |
1 |
Won-N |
Outer |
68808 |
1638 |
404 |
99.43% |
8 |
7 |
358 |
Won-ORF1ab |
Outer |
70240 |
337 |
273 |
99.61% |
5 |
2 |
313 |
Won-S |
Outer |
68057 |
234 |
2559 |
96.39% |
5 |
1 |
0 |
Yip-ORF1ab |
Outer |
69750 |
343 |
757 |
98.93% |
5 |
1 |
1 |
Young-N |
Probe |
0 |
70498 |
352 |
99.50% |
0 |
5 |
1 |
Young-ORF1ab |
Probe |
70452 |
237 |
161 |
99.77% |
5 |
1 |
0 |
Young-S |
Probe |
69634 |
704 |
512 |
99.28% |
4 |
1 |
0 |
Updated to 74,584 COVID-19 WGS from GISAID.
Table 1. Results from PSET analysis. The five Noblis assays were compared alongside the four assays from Corman and three assays from the CDC. Along with assays from China, Hong Kong, Thailand, Japan, France, South Korea, and Singapore. Each assay was tested using SARS-CoV-2 as the intended target. All off-target hits (TN, PF, FP) are to entries in NCBI BLAST databases (nt and env_nt).
identifier |
type |
PT |
TP |
FN |
Percent True |
PF |
FP |
TN |
Noblis.12 |
Probe |
73921 |
326 |
337 |
99.55% |
0 |
0 |
680 |
Noblis.40 |
Probe |
72484 |
1883 |
217 |
99.71% |
0 |
1 |
1420 |
Noblis.42 |
Probe |
74005 |
220 |
359 |
99.52% |
0 |
2 |
1136 |
Noblis.44 |
Probe |
73498 |
372 |
714 |
99.04% |
0 |
1 |
1786 |
Noblis.57 |
Probe |
73100 |
721 |
763 |
98.98% |
0 |
1 |
853 |
ncov_e_gene |
Probe |
73942 |
229 |
413 |
99.45% |
361 |
15 |
53 |
ncov_n_gene |
Probe |
73151 |
936 |
497 |
99.33% |
0 |
340 |
72 |
ncov_rdrp_1 |
Probe |
0 |
74352 |
232 |
99.69% |
433 |
105 |
5967 |
ncov_rdrp_2 |
Probe |
5 |
74367 |
212 |
99.72% |
2 |
73 |
5916 |
cdc_n1 |
Probe |
72089 |
2311 |
184 |
99.75% |
0 |
2 |
381 |
cdc_n2 |
Probe |
73090 |
599 |
895 |
98.80% |
0 |
1 |
372 |
cdc_n3 |
Probe |
73257 |
1017 |
310 |
99.58% |
1 |
353 |
36 |
China_N |
Probe |
48896 |
1028 |
24660 |
66.94% |
0 |
2 |
691 |
China_ORF1ab |
Probe |
71449 |
552 |
2583 |
96.54% |
1 |
0 |
367 |
France_nCoV_IP2 |
Probe |
74020 |
306 |
258 |
99.65% |
1 |
0 |
367 |
France_nCoV_IP4 |
Probe |
73951 |
484 |
149 |
99.80% |
0 |
0 |
1190 |
HKU-N |
Probe |
72935 |
763 |
886 |
98.81% |
327 |
33 |
34 |
HKU-ORF1b-nsp14 |
Probe |
73809 |
549 |
226 |
99.70% |
324 |
29 |
452 |
Japan_NIID_2019-nCOV_N |
Probe |
0 |
73656 |
928 |
98.76% |
0 |
0 |
384 |
Japan_NIID_WH-1_F24381 |
Outer |
73011 |
1101 |
472 |
99.37% |
0 |
1 |
601 |
Japan_NIID_WH-1_F501 |
Outer |
72976 |
1056 |
552 |
99.26% |
0 |
1 |
370 |
Japan_NIID_WH-1_F509 |
Outer |
73053 |
882 |
649 |
99.13% |
1 |
0 |
369 |
Japan_NIID_WH-1_Seq_F24383 |
Outer |
72973 |
1126 |
485 |
99.35% |
0 |
0 |
606 |
Japan_NIID_WH-1_Seq_F519 |
Outer |
72850 |
708 |
1026 |
98.62% |
0 |
1 |
369 |
Japan_WuhanCoV-spk1 |
Outer |
73162 |
937 |
485 |
99.35% |
1 |
1 |
594 |
Thailand_WH-NIC_N |
Probe |
73512 |
865 |
207 |
99.72% |
0 |
2 |
375 |
Chan-N |
Probe |
73166 |
526 |
892 |
98.80% |
4 |
3 |
353 |
Chan-ORF1ab |
Probe |
0 |
73737 |
847 |
98.86% |
0 |
5 |
2 |
Chan-S |
Probe |
72979 |
286 |
1319 |
98.23% |
5 |
0 |
2 |
Niu-E |
Probe |
73774 |
356 |
454 |
99.39% |
26 |
359 |
0 |
Won-E |
Outer |
2 |
74216 |
366 |
99.51% |
0 |
384 |
1 |
Won-N |
Outer |
72467 |
1682 |
435 |
99.42% |
8 |
7 |
358 |
Won-ORF1ab |
Outer |
73957 |
351 |
276 |
99.63% |
5 |
2 |
313 |
Won-S |
Outer |
71568 |
240 |
2776 |
96.28% |
5 |
1 |
0 |
Yip-ORF1ab |
Outer |
73398 |
396 |
790 |
98.94% |
5 |
1 |
1 |
Young-N |
Probe |
0 |
74206 |
378 |
99.49% |
0 |
5 |
1 |
Young-ORF1ab |
Probe |
74123 |
253 |
208 |
99.72% |
5 |
1 |
0 |
Young-S |
Probe |
73193 |
732 |
659 |
99.12% |
4 |
1 |
0 |
Updated to 78,448 COVID-19 WGS from GISAID.
Table 1. Results from PSET analysis. The five Noblis assays were compared alongside the four assays from Corman and three assays from the CDC. Along with assays from China, Hong Kong, Thailand, Japan, France, South Korea, and Singapore. Each assay was tested using SARS-CoV-2 as the intended target. All off-target hits (TN, PF, FP) are to entries in NCBI BLAST databases (nt and env_nt).
identifier |
type |
PT |
TP |
FN |
Percent True |
PF |
FP |
TN |
Noblis.12 |
Probe |
77728 |
353 |
367 |
99.53% |
0 |
0 |
680 |
Noblis.40 |
Probe |
76308 |
1912 |
228 |
99.71% |
0 |
1 |
1420 |
Noblis.42 |
Probe |
77815 |
251 |
382 |
99.51% |
0 |
2 |
1136 |
Noblis.44 |
Probe |
77296 |
394 |
758 |
99.03% |
0 |
1 |
1786 |
Noblis.57 |
Probe |
76873 |
740 |
835 |
98.94% |
0 |
1 |
853 |
ncov_e_gene |
Probe |
77757 |
241 |
450 |
99.43% |
361 |
15 |
53 |
ncov_n_gene |
Probe |
76826 |
1001 |
621 |
99.21% |
0 |
340 |
72 |
ncov_rdrp_1 |
Probe |
0 |
78186 |
262 |
99.67% |
433 |
105 |
5967 |
ncov_rdrp_2 |
Probe |
6 |
78206 |
236 |
99.70% |
2 |
73 |
5916 |
cdc_n1 |
Probe |
75749 |
2467 |
232 |
99.70% |
0 |
2 |
381 |
cdc_n2 |
Probe |
76688 |
741 |
1019 |
98.70% |
0 |
1 |
372 |
cdc_n3 |
Probe |
76988 |
1051 |
409 |
99.48% |
1 |
353 |
36 |
China_N |
Probe |
51505 |
1174 |
25769 |
67.15% |
0 |
2 |
691 |
China_ORF1ab |
Probe |
75229 |
569 |
2650 |
96.62% |
1 |
0 |
367 |
France_nCoV_IP2 |
Probe |
77832 |
317 |
299 |
99.62% |
1 |
0 |
367 |
France_nCoV_IP4 |
Probe |
77782 |
505 |
161 |
99.79% |
0 |
0 |
1190 |
HKU-N |
Probe |
76513 |
925 |
1010 |
98.71% |
327 |
33 |
34 |
HKU-ORF1b-nsp14 |
Probe |
77636 |
578 |
234 |
99.70% |
324 |
29 |
452 |
Japan_NIID_2019-nCOV_N |
Probe |
0 |
77390 |
1058 |
98.65% |
0 |
0 |
384 |
Japan_NIID_WH-1_F24381 |
Outer |
76797 |
1124 |
527 |
99.33% |
0 |
1 |
601 |
Japan_NIID_WH-1_F501 |
Outer |
76694 |
1098 |
656 |
99.16% |
0 |
1 |
370 |
Japan_NIID_WH-1_F509 |
Outer |
76776 |
918 |
754 |
99.04% |
1 |
0 |
369 |
Japan_NIID_WH-1_Seq_F24383 |
Outer |
76760 |
1147 |
541 |
99.31% |
0 |
0 |
606 |
Japan_NIID_WH-1_Seq_F519 |
Outer |
76571 |
734 |
1143 |
98.54% |
0 |
1 |
369 |
Japan_WuhanCoV-spk1 |
Outer |
76953 |
957 |
538 |
99.31% |
1 |
1 |
594 |
Thailand_WH-NIC_N |
Probe |
77290 |
899 |
259 |
99.67% |
0 |
2 |
375 |
Chan-N |
Probe |
76864 |
559 |
1025 |
98.69% |
4 |
3 |
353 |
Chan-ORF1ab |
Probe |
0 |
77546 |
902 |
98.85% |
0 |
5 |
2 |
Chan-S |
Probe |
76691 |
310 |
1447 |
98.16% |
5 |
0 |
2 |
Niu-E |
Probe |
77581 |
374 |
493 |
99.37% |
26 |
359 |
0 |
Won-E |
Outer |
2 |
78050 |
396 |
99.50% |
0 |
384 |
1 |
Won-N |
Outer |
76166 |
1736 |
546 |
99.30% |
8 |
7 |
358 |
Won-ORF1ab |
Outer |
77779 |
373 |
296 |
99.62% |
5 |
2 |
313 |
Won-S |
Outer |
75218 |
251 |
2979 |
96.20% |
5 |
1 |
0 |
Yip-ORF1ab |
Outer |
77187 |
409 |
852 |
98.91% |
5 |
1 |
1 |
Young-N |
Probe |
0 |
77962 |
486 |
99.38% |
0 |
5 |
1 |
Young-ORF1ab |
Probe |
77900 |
326 |
222 |
99.72% |
5 |
1 |
0 |
Young-S |
Probe |
76962 |
767 |
719 |
99.08% |
4 |
1 |
0 |
Updated to 81,375 COVID-19 WGS from GISAID.
Table 1. Results from PSET analysis. The five Noblis assays were compared alongside the four assays from Corman and three assays from the CDC. Along with assays from China, Hong Kong, Thailand, Japan, France, South Korea, and Singapore. Each assay was tested using SARS-CoV-2 as the intended target. All off-target hits (TN, PF, FP) are to entries in NCBI BLAST databases (nt and env_nt).
identifier |
type |
PT |
TP |
FN |
Percent True |
PF |
FP |
TN |
Noblis.12 |
Probe |
80629 |
375 |
371 |
99.54% |
0 |
0 |
680 |
Noblis.40 |
Probe |
79217 |
1929 |
229 |
99.72% |
0 |
1 |
1420 |
Noblis.42 |
Probe |
80711 |
279 |
385 |
99.53% |
0 |
2 |
1136 |
Noblis.44 |
Probe |
80193 |
416 |
766 |
99.06% |
0 |
1 |
1786 |
Noblis.57 |
Probe |
79696 |
795 |
884 |
98.91% |
0 |
1 |
853 |
ncov_e_gene |
Probe |
80662 |
253 |
460 |
99.43% |
361 |
15 |
53 |
ncov_n_gene |
Probe |
79688 |
1040 |
647 |
99.20% |
0 |
340 |
72 |
ncov_rdrp_1 |
Probe |
0 |
81109 |
266 |
99.67% |
433 |
105 |
5967 |
ncov_rdrp_2 |
Probe |
6 |
81129 |
240 |
99.71% |
2 |
73 |
5916 |
cdc_n1 |
Probe |
78614 |
2517 |
244 |
99.70% |
0 |
2 |
381 |
cdc_n2 |
Probe |
79527 |
773 |
1075 |
98.68% |
0 |
1 |
372 |
cdc_n3 |
Probe |
79854 |
1095 |
426 |
99.48% |
1 |
353 |
36 |
China_N |
Probe |
53206 |
1218 |
26951 |
66.88% |
0 |
2 |
691 |
China_ORF1ab |
Probe |
78024 |
586 |
2765 |
96.60% |
1 |
0 |
367 |
France_nCoV_IP2 |
Probe |
80744 |
326 |
305 |
99.63% |
1 |
0 |
367 |
France_nCoV_IP4 |
Probe |
80688 |
521 |
166 |
99.80% |
0 |
0 |
1190 |
HKU-N |
Probe |
79290 |
1012 |
1073 |
98.68% |
327 |
33 |
34 |
HKU-ORF1b-nsp14 |
Probe |
80555 |
585 |
235 |
99.71% |
324 |
29 |
452 |
Japan_NIID_2019-nCOV_N |
Probe |
0 |
80250 |
1125 |
98.62% |
0 |
0 |
384 |
Japan_NIID_WH-1_F24381 |
Outer |
79663 |
1175 |
537 |
99.34% |
0 |
1 |
601 |
Japan_NIID_WH-1_F501 |
Outer |
79542 |
1149 |
684 |
99.16% |
0 |
1 |
370 |
Japan_NIID_WH-1_F509 |
Outer |
79641 |
953 |
781 |
99.04% |
1 |
0 |
369 |
Japan_NIID_WH-1_Seq_F24383 |
Outer |
79624 |
1200 |
551 |
99.32% |
0 |
0 |
606 |
Japan_NIID_WH-1_Seq_F519 |
Outer |
79428 |
769 |
1178 |
98.55% |
0 |
1 |
369 |
Japan_WuhanCoV-spk1 |
Outer |
79824 |
1003 |
548 |
99.33% |
1 |
1 |
594 |
Thailand_WH-NIC_N |
Probe |
80166 |
938 |
271 |
99.67% |
0 |
2 |
375 |
Chan-N |
Probe |
79664 |
622 |
1089 |
98.66% |
4 |
3 |
353 |
Chan-ORF1ab |
Probe |
0 |
80465 |
910 |
98.88% |
0 |
5 |
2 |
Chan-S |
Probe |
79578 |
317 |
1480 |
98.18% |
5 |
0 |
2 |
Niu-E |
Probe |
80483 |
387 |
505 |
99.38% |
26 |
359 |
0 |
Won-E |
Outer |
2 |
80967 |
406 |
99.50% |
0 |
384 |
1 |
Won-N |
Outer |
79037 |
1767 |
571 |
99.30% |
8 |
7 |
358 |
Won-ORF1ab |
Outer |
80690 |
385 |
300 |
99.63% |
5 |
2 |
313 |
Won-S |
Outer |
77946 |
263 |
3166 |
96.11% |
5 |
1 |
0 |
Yip-ORF1ab |
Outer |
80055 |
433 |
887 |
98.91% |
5 |
1 |
1 |
Young-N |
Probe |
0 |
80875 |
500 |
99.39% |
0 |
5 |
1 |
Young-ORF1ab |
Probe |
80786 |
362 |
227 |
99.72% |
5 |
1 |
0 |
Young-S |
Probe |
79676 |
802 |
897 |
98.90% |
4 |
1 |
0 |
Updated to 155,090 COVID-19 WGS from GISAID.
Table 1. Results from PSET analysis. The five Noblis assays were compared alongside the four assays from Corman and three assays from the CDC. Along with assays from China, Hong Kong, Thailand, Japan, France, South Korea, and Singapore. Each assay was tested using SARS-CoV-2 as the intended target. All off-target hits (TN, PF, FP) are to entries in NCBI BLAST databases (nt and env_nt).
identifier |
type |
PT |
TP |
FN |
Percent True |
PF |
FP |
TN |
Noblis.12 |
Probe |
151389 |
3124 |
577 |
99.63% |
0 |
0 |
680 |
Noblis.40 |
Probe |
151690 |
2939 |
461 |
99.70% |
0 |
1 |
1420 |
Noblis.42 |
Probe |
153741 |
685 |
664 |
99.57% |
0 |
2 |
1136 |
Noblis.44 |
Probe |
152825 |
1123 |
1142 |
99.26% |
0 |
1 |
1786 |
Noblis.57 |
Probe |
151126 |
1667 |
2297 |
98.52% |
0 |
1 |
853 |
ncov_e_gene |
Probe |
153740 |
484 |
866 |
99.44% |
361 |
15 |
53 |
ncov_n_gene |
Probe |
149783 |
3679 |
1628 |
98.95% |
0 |
340 |
72 |
ncov_rdrp_1 |
Probe |
0 |
154278 |
812 |
99.48% |
433 |
105 |
5967 |
ncov_rdrp_2 |
Probe |
8 |
154308 |
774 |
99.50% |
2 |
73 |
5916 |
cdc_n1 |
Probe |
150613 |
4099 |
378 |
99.76% |
0 |
2 |
381 |
cdc_n2 |
Probe |
149756 |
3617 |
1717 |
98.89% |
0 |
1 |
372 |
cdc_n3 |
Probe |
152268 |
2067 |
755 |
99.51% |
1 |
353 |
36 |
China_N |
Probe |
89180 |
3746 |
62164 |
59.92% |
0 |
2 |
691 |
China_ORF1ab |
Probe |
149836 |
960 |
4294 |
97.23% |
1 |
0 |
367 |
France_nCoV_IP2 |
Probe |
153767 |
779 |
544 |
99.65% |
1 |
0 |
367 |
France_nCoV_IP4 |
Probe |
153580 |
1190 |
320 |
99.79% |
0 |
0 |
1190 |
HKU-N |
Probe |
151013 |
2353 |
1724 |
98.89% |
327 |
33 |
34 |
HKU-ORF1b-nsp14 |
Probe |
152940 |
1810 |
340 |
99.78% |
324 |
29 |
452 |
Japan_NIID_2019-nCOV_N |
Probe |
0 |
153281 |
1809 |
98.83% |
0 |
0 |
384 |
Japan_NIID_WH-1_F24381 |
Outer |
151755 |
1856 |
1479 |
99.05% |
0 |
1 |
601 |
Japan_NIID_WH-1_F501 |
Outer |
152321 |
1804 |
965 |
99.38% |
0 |
1 |
370 |
Japan_NIID_WH-1_F509 |
Outer |
151285 |
2736 |
1069 |
99.31% |
1 |
0 |
369 |
Japan_NIID_WH-1_Seq_F24383 |
Outer |
151705 |
1890 |
1495 |
99.04% |
0 |
0 |
606 |
Japan_NIID_WH-1_Seq_F519 |
Outer |
151813 |
1536 |
1741 |
98.88% |
0 |
1 |
369 |
Japan_WuhanCoV-spk1 |
Outer |
152152 |
1440 |
1498 |
99.03% |
1 |
1 |
594 |
Thailand_WH-NIC_N |
Probe |
152416 |
2258 |
416 |
99.73% |
0 |
2 |
375 |
Chan-N |
Probe |
150115 |
3213 |
1762 |
98.86% |
4 |
3 |
353 |
Chan-ORF1ab |
Probe |
2 |
153697 |
1391 |
99.10% |
0 |
5 |
2 |
Chan-S |
Probe |
152099 |
677 |
2314 |
98.51% |
5 |
0 |
2 |
Niu-E |
Probe |
152976 |
1191 |
923 |
99.40% |
26 |
359 |
0 |
Won-E |
Outer |
5 |
154304 |
781 |
99.50% |
0 |
384 |
1 |
Won-N |
Outer |
149757 |
3865 |
1468 |
99.05% |
8 |
7 |
358 |
Won-ORF1ab |
Outer |
153513 |
745 |
832 |
99.46% |
5 |
2 |
313 |
Won-S |
Outer |
147646 |
679 |
6765 |
95.64% |
5 |
1 |
0 |
Yip-ORF1ab |
Outer |
152311 |
1110 |
1669 |
98.92% |
5 |
1 |
1 |
Young-N |
Probe |
0 |
154189 |
901 |
99.42% |
0 |
5 |
1 |
Young-ORF1ab |
Probe |
151420 |
2980 |
690 |
99.56% |
5 |
1 |
0 |
Young-S |
Probe |
150084 |
2610 |
2396 |
98.46% |
4 |
1 |
0 |
Updated to 429,535 COVID-19 WGS from GISAID.
Table 1. Results from PSET analysis. The five Noblis assays were compared alongside the four assays from Corman and three assays from the CDC. Along with assays from China, Hong Kong, Thailand, Japan, France, South Korea, and Singapore. Each assay was tested using SARS-CoV-2 as the intended target. All off-target hits (TN, PF, FP) are to entries in NCBI BLAST databases (nt and env_nt). *edited 2/2 to include 5 additional assays.
Assay |
type |
PT |
TP |
FN |
Percent True |
PF |
FP |
TN |
Noblis.12 |
Probe |
418132 |
9890 |
1513 |
99.65% |
0 |
0 |
680 |
Noblis.40 |
Probe |
422357 |
6189 |
989 |
99.77% |
0 |
1 |
1420 |
Noblis.42 |
Probe |
425135 |
3027 |
1373 |
99.68% |
0 |
2 |
1136 |
Noblis.44 |
Probe |
423566 |
3726 |
2243 |
99.48% |
0 |
1 |
1786 |
Noblis.57 |
Probe |
420120 |
4728 |
4687 |
98.91% |
0 |
1 |
853 |
ncov_e_gene |
Probe |
425568 |
1533 |
2434 |
99.43% |
361 |
15 |
53 |
ncov_n_gene |
Probe |
412931 |
12717 |
3887 |
99.10% |
0 |
340 |
72 |
ncov_rdrp_1 |
Probe |
0 |
427853 |
1682 |
99.61% |
433 |
105 |
5967 |
ncov_rdrp_2 |
Probe |
15 |
428021 |
1499 |
99.65% |
2 |
73 |
5916 |
cdc_n1 |
Probe |
413781 |
14665 |
1089 |
99.75% |
0 |
2 |
381 |
cdc_n2 |
Probe |
413697 |
12867 |
2971 |
99.31% |
0 |
1 |
372 |
cdc_n3 |
Probe |
415446 |
12633 |
1456 |
99.66% |
1 |
353 |
36 |
China_N |
Probe |
250112 |
23943 |
155480 |
63.80% |
0 |
2 |
691 |
China_ORF1ab |
Probe |
417104 |
3245 |
9186 |
97.86% |
1 |
0 |
367 |
France_nCoV_IP2 |
Probe |
424068 |
3058 |
2409 |
99.44% |
1 |
0 |
367 |
France_nCoV_IP4 |
Probe |
423557 |
5197 |
781 |
99.82% |
0 |
0 |
1190 |
HKU-N |
Probe |
416560 |
9882 |
3093 |
99.28% |
327 |
33 |
34 |
HKU-ORF1b-nsp14 |
Probe |
425082 |
3616 |
837 |
99.81% |
324 |
29 |
452 |
Japan_NIID_2019-nCOV_N |
Probe |
0 |
426277 |
3258 |
99.24% |
0 |
0 |
384 |
Japan_NIID_WH-1_F24381 |
Outer |
421243 |
5282 |
3010 |
99.30% |
0 |
1 |
601 |
Japan_NIID_WH-1_F501 |
Outer |
422571 |
4379 |
2585 |
99.40% |
0 |
1 |
370 |
Japan_NIID_WH-1_F509 |
Outer |
419030 |
7716 |
2789 |
99.35% |
1 |
0 |
369 |
Japan_NIID_WH-1_Seq_F24383 |
Outer |
421039 |
5450 |
3046 |
99.29% |
0 |
0 |
606 |
Japan_NIID_WH-1_Seq_F519 |
Outer |
418816 |
4946 |
5773 |
98.66% |
0 |
1 |
369 |
Japan_WuhanCoV-spk1 |
Outer |
423033 |
3482 |
3020 |
99.30% |
1 |
1 |
594 |
Thailand_WH-NIC_N |
Probe |
420302 |
8063 |
1170 |
99.73% |
0 |
2 |
375 |
Chan-N |
Probe |
414334 |
11996 |
3205 |
99.25% |
4 |
3 |
353 |
Chan-ORF1ab |
Probe |
5 |
424942 |
4588 |
98.93% |
0 |
5 |
2 |
Chan-S |
Probe |
420124 |
3359 |
6052 |
98.59% |
5 |
0 |
2 |
Niu-E |
Probe |
422447 |
4543 |
2545 |
99.41% |
26 |
359 |
0 |
Won-E |
Outer |
6 |
427327 |
2202 |
99.49% |
0 |
384 |
1 |
Won-N |
Outer |
416703 |
9242 |
3590 |
99.16% |
8 |
7 |
358 |
Won-ORF1ab |
Outer |
425905 |
2027 |
1603 |
99.63% |
5 |
2 |
313 |
Won-S |
Outer |
411918 |
2402 |
15215 |
96.46% |
5 |
1 |
0 |
Yip-ORF1ab |
Outer |
421949 |
3155 |
4431 |
98.97% |
5 |
1 |
1 |
Young-N |
Probe |
1 |
428083 |
1451 |
99.66% |
0 |
5 |
1 |
Young-ORF1ab |
Probe |
420062 |
8220 |
1253 |
99.71% |
5 |
1 |
0 |
Young-S |
Probe |
367410 |
13478 |
48647 |
88.67% |
4 |
1 |
0 |
C1_COV_ORF1a |
Probe |
411789 |
6109 |
11637 |
97.29% |
0 |
0 |
0 |
C2_COV_ORF1b |
Probe |
417280 |
10607 |
1648 |
99.62% |
0 |
0 |
0 |
C3_COV_ORF3a |
Probe |
385590 |
31374 |
12571 |
97.07% |
0 |
0 |
0 |
C4_COV_ORF8 |
Probe |
371318 |
51082 |
7135 |
98.34% |
0 |
0 |
0 |
C5_COV_S_gene |
Probe |
421619 |
5116 |
2800 |
99.35% |
0 |
0 |
0 |
Updated to 466,524 COVID-19 WGS from GISAID.
Table 1. Results from PSET analysis. The five Noblis assays were compared alongside the four assays from Corman and three assays from the CDC. Along with assays from China, Hong Kong, Thailand, Japan, France, South Korea, and Singapore. Each assay was tested using SARS-CoV-2 as the intended target. All off-target hits (TN, PF, FP) are to entries in NCBI BLAST databases (nt and env_nt). *edited 2/2 to include 5 additional assays.
Assay |
PT |
TP |
FN |
Percent True |
PF |
FP |
TN |
Noblis.12 |
454125 |
10499 |
1900 |
99.59% |
0 |
0 |
680 |
Noblis.40 |
458704 |
6644 |
1176 |
99.75% |
0 |
1 |
1420 |
Noblis.42 |
461350 |
3393 |
1781 |
99.62% |
0 |
2 |
1136 |
Noblis.44 |
459680 |
4097 |
2747 |
99.41% |
0 |
1 |
1786 |
Noblis.57 |
455564 |
5232 |
5728 |
98.77% |
0 |
1 |
853 |
ncov_e_gene |
461926 |
1752 |
2846 |
99.39% |
361 |
15 |
53 |
ncov_n_gene |
448606 |
13640 |
4278 |
99.08% |
0 |
340 |
72 |
ncov_rdrp_1 |
0 |
464006 |
2518 |
99.46% |
433 |
105 |
5967 |
ncov_rdrp_2 |
16 |
464254 |
2254 |
99.52% |
2 |
73 |
5916 |
cdc_n1 |
449212 |
15919 |
1393 |
99.70% |
0 |
2 |
381 |
cdc_n2 |
449423 |
13796 |
3305 |
99.29% |
0 |
1 |
372 |
cdc_n3 |
448548 |
16074 |
1902 |
99.59% |
1 |
353 |
36 |
China_N |
263858 |
28328 |
174338 |
62.63% |
0 |
2 |
691 |
China_ORF1ab |
452935 |
3603 |
9986 |
97.86% |
1 |
0 |
367 |
France_nCoV_IP2 |
460117 |
3537 |
2870 |
99.38% |
1 |
0 |
367 |
France_nCoV_IP4 |
459488 |
5955 |
1081 |
99.77% |
0 |
0 |
1190 |
HKU-N |
452261 |
10734 |
3529 |
99.24% |
327 |
33 |
34 |
HKU-ORF1b-nsp14 |
461355 |
3951 |
1218 |
99.74% |
324 |
29 |
452 |
Japan_NIID_2019-nCOV_N |
0 |
462783 |
3741 |
99.20% |
0 |
0 |
384 |
Japan_NIID_WH-1_F24381 |
456883 |
5750 |
3891 |
99.17% |
0 |
1 |
601 |
Japan_NIID_WH-1_F501 |
458829 |
4663 |
3032 |
99.35% |
0 |
1 |
370 |
Japan_NIID_WH-1_F509 |
455000 |
8305 |
3219 |
99.31% |
1 |
0 |
369 |
Japan_NIID_WH-1_Seq_F24383 |
456677 |
5914 |
3933 |
99.16% |
0 |
0 |
606 |
Japan_NIID_WH-1_Seq_F519 |
454746 |
5480 |
6298 |
98.65% |
0 |
1 |
369 |
Japan_WuhanCoV-spk1 |
458563 |
4051 |
3910 |
99.16% |
1 |
1 |
594 |
Thailand_WH-NIC_N |
456149 |
8902 |
1473 |
99.68% |
0 |
2 |
375 |
Chan-N |
449760 |
13098 |
3666 |
99.21% |
4 |
3 |
353 |
Chan-ORF1ab |
5 |
461374 |
5145 |
98.90% |
0 |
5 |
2 |
Chan-S |
455718 |
3978 |
6828 |
98.54% |
5 |
0 |
2 |
Niu-E |
458497 |
5053 |
2974 |
99.36% |
26 |
359 |
0 |
Won-E |
7 |
463939 |
2578 |
99.45% |
0 |
384 |
1 |
Won-N |
452543 |
10040 |
3941 |
99.16% |
8 |
7 |
358 |
Won-ORF1ab |
461759 |
2445 |
2320 |
99.50% |
5 |
2 |
313 |
Won-S |
447723 |
2713 |
16088 |
96.55% |
5 |
1 |
0 |
Yip-ORF1ab |
458076 |
3477 |
4971 |
98.93% |
5 |
1 |
1 |
Young-N |
1 |
464658 |
1865 |
99.60% |
0 |
5 |
1 |
Young-ORF1ab |
456396 |
8564 |
1564 |
99.66% |
5 |
1 |
0 |
Young-S |
392575 |
15258 |
58691 |
87.42% |
4 |
1 |
0 |
C1_COV_ORF1a |
447079 |
6777 |
12668 |
97.28% |
0 |
0 |
0 |
C2_COV_ORF1b |
452758 |
11713 |
2053 |
99.56% |
0 |
0 |
0 |
C3_COV_ORF3a |
415896 |
37202 |
13426 |
97.12% |
0 |
0 |
0 |
C4_COV_ORF8 |
397705 |
60858 |
7961 |
98.29% |
0 |
0 |
0 |
C5_COV_S_gene |
457226 |
5598 |
3700 |
99.21% |
0 |
0 |
0 |
Updated to 507,323 COVID-19 WGS from GISAID.
Table 1. Results from PSET analysis. The five Noblis assays were compared alongside the four assays from Corman and three assays from the CDC. Along with assays from China, Hong Kong, Thailand, Japan, France, South Korea, and Singapore. Each assay was tested using SARS-CoV-2 as the intended target. All off-target hits (TN, PF, FP) are to entries in NCBI BLAST databases (nt and env_nt). *edited 2/2 to include 5 additional assays.
assay |
PT |
TP |
FN |
Percent True |
PF |
FP |
TN |
Noblis.12 |
494230 |
11101 |
1992 |
99.61% |
0 |
0 |
680 |
Noblis.40 |
499141 |
6954 |
1228 |
99.76% |
0 |
1 |
1420 |
Noblis.42 |
501587 |
3845 |
1891 |
99.63% |
0 |
2 |
1136 |
Noblis.44 |
499889 |
4450 |
2984 |
99.41% |
0 |
1 |
1786 |
Noblis.57 |
495554 |
5690 |
6079 |
98.80% |
0 |
1 |
853 |
ncov_e_gene |
502382 |
1902 |
3039 |
99.40% |
361 |
15 |
53 |
ncov_n_gene |
488006 |
14617 |
4700 |
99.07% |
0 |
340 |
72 |
ncov_rdrp_1 |
0 |
504677 |
2646 |
99.48% |
433 |
105 |
5967 |
ncov_rdrp_2 |
16 |
504957 |
2350 |
99.54% |
2 |
73 |
5916 |
cdc_n1 |
488471 |
17396 |
1456 |
99.71% |
0 |
2 |
381 |
cdc_n2 |
488978 |
14940 |
3405 |
99.33% |
0 |
1 |
372 |
cdc_n3 |
488204 |
17106 |
2013 |
99.60% |
1 |
353 |
36 |
China_N |
279059 |
31342 |
196922 |
61.18% |
0 |
2 |
691 |
China_ORF1ab |
492603 |
4055 |
10665 |
97.90% |
1 |
0 |
367 |
France_nCoV_IP2 |
500117 |
3999 |
3207 |
99.37% |
1 |
0 |
367 |
France_nCoV_IP4 |
498969 |
7209 |
1145 |
99.77% |
0 |
0 |
1190 |
HKU-N |
491804 |
11889 |
3630 |
99.28% |
327 |
33 |
34 |
HKU-ORF1b-nsp14 |
501877 |
4181 |
1265 |
99.75% |
324 |
29 |
452 |
Japan_NIID_2019-nCOV_N |
0 |
503471 |
3852 |
99.24% |
0 |
0 |
384 |
Japan_NIID_WH-1_F24381 |
496921 |
6295 |
4107 |
99.19% |
0 |
1 |
601 |
Japan_NIID_WH-1_F501 |
499044 |
5044 |
3235 |
99.36% |
0 |
1 |
370 |
Japan_NIID_WH-1_F509 |
494915 |
8978 |
3430 |
99.32% |
1 |
0 |
369 |
Japan_NIID_WH-1_Seq_F24383 |
496682 |
6491 |
4150 |
99.18% |
0 |
0 |
606 |
Japan_NIID_WH-1_Seq_F519 |
494624 |
6040 |
6659 |
98.69% |
0 |
1 |
369 |
Japan_WuhanCoV-spk1 |
498900 |
4290 |
4133 |
99.19% |
1 |
1 |
594 |
Thailand_WH-NIC_N |
495941 |
9848 |
1534 |
99.70% |
0 |
2 |
375 |
Chan-N |
489511 |
14036 |
3776 |
99.26% |
4 |
3 |
353 |
Chan-ORF1ab |
6 |
501750 |
5567 |
98.90% |
0 |
5 |
2 |
Chan-S |
495106 |
4758 |
7459 |
98.53% |
5 |
0 |
2 |
Niu-E |
498719 |
5429 |
3175 |
99.37% |
26 |
359 |
0 |
Won-E |
7 |
504559 |
2757 |
99.46% |
0 |
384 |
1 |
Won-N |
492335 |
10637 |
4351 |
99.14% |
8 |
7 |
358 |
Won-ORF1ab |
502141 |
2742 |
2440 |
99.52% |
5 |
2 |
313 |
Won-S |
487318 |
3020 |
16985 |
96.65% |
5 |
1 |
0 |
Yip-ORF1ab |
498221 |
3849 |
5253 |
98.96% |
5 |
1 |
1 |
Young-N |
1 |
505333 |
1989 |
99.61% |
0 |
5 |
1 |
Young-ORF1ab |
496665 |
8997 |
1661 |
99.67% |
5 |
1 |
0 |
Young-S |
411307 |
16905 |
79111 |
84.41% |
4 |
1 |
0 |
C1_COV_ORF1a |
485703 |
7396 |
14224 |
97.20% |
0 |
0 |
0 |
C2_COV_ORF1b |
492279 |
12891 |
2153 |
99.58% |
0 |
0 |
0 |
C3_COV_ORF3a |
450634 |
41962 |
14727 |
97.10% |
0 |
0 |
0 |
C4_COV_ORF8 |
417307 |
81555 |
8461 |
98.33% |
0 |
0 |
0 |
C5_COV_S_gene |
496985 |
6416 |
3922 |
99.23% |
0 |
0 |
0 |
Updated to 565,366 COVID-19 WGS from GISAID.
Table 1. Results from PSET analysis. The five Noblis assays were compared alongside the four assays from Corman and three assays from the CDC. Along with assays from China, Hong Kong, Thailand, Japan, France, South Korea, and Singapore. Each assay was tested using SARS-CoV-2 as the intended target. All off-target hits (TN, PF, FP) are to entries in NCBI BLAST databases (nt and env_nt). *edited 2/2 to include 5 additional assays.
assay |
PT |
TP |
FN |
Percent True |
PF |
FP |
TN |
Noblis.12 |
550666 |
12329 |
2371 |
99.58% |
0 |
0 |
680 |
Noblis.40 |
556093 |
7876 |
1397 |
99.75% |
0 |
1 |
1420 |
Noblis.42 |
557860 |
4643 |
2863 |
99.49% |
0 |
2 |
1136 |
Noblis.44 |
555976 |
5236 |
4154 |
99.27% |
0 |
1 |
1786 |
Noblis.57 |
550426 |
6426 |
8514 |
98.49% |
0 |
1 |
853 |
ncov_e_gene |
559501 |
2135 |
3730 |
99.34% |
361 |
15 |
53 |
ncov_n_gene |
543949 |
15931 |
5486 |
99.03% |
0 |
340 |
72 |
ncov_rdrp_1 |
0 |
560329 |
5037 |
99.11% |
433 |
105 |
5967 |
ncov_rdrp_2 |
16 |
560651 |
4699 |
99.17% |
2 |
73 |
5916 |
cdc_n1 |
542650 |
19854 |
2862 |
99.49% |
0 |
2 |
381 |
cdc_n2 |
542621 |
17193 |
5552 |
99.02% |
0 |
1 |
372 |
cdc_n3 |
543000 |
19063 |
3303 |
99.42% |
1 |
353 |
36 |
China_N |
301247 |
39356 |
224763 |
60.24% |
0 |
2 |
691 |
China_ORF1ab |
547989 |
4790 |
12587 |
97.77% |
1 |
0 |
367 |
France_nCoV_IP2 |
556064 |
4682 |
4620 |
99.18% |
1 |
0 |
367 |
France_nCoV_IP4 |
554800 |
8835 |
1731 |
99.69% |
0 |
0 |
1190 |
HKU-N |
545445 |
14138 |
5783 |
98.98% |
327 |
33 |
34 |
HKU-ORF1b-nsp14 |
558319 |
4608 |
2439 |
99.57% |
324 |
29 |
452 |
Japan_NIID_2019-nCOV_N |
0 |
559362 |
6004 |
98.94% |
0 |
0 |
384 |
Japan_NIID_WH-1_F24381 |
551867 |
7153 |
6346 |
98.88% |
0 |
1 |
601 |
Japan_NIID_WH-1_F501 |
555798 |
5516 |
4052 |
99.28% |
0 |
1 |
370 |
Japan_NIID_WH-1_F509 |
551045 |
10081 |
4240 |
99.25% |
1 |
0 |
369 |
Japan_NIID_WH-1_Seq_F24383 |
551598 |
7371 |
6397 |
98.87% |
0 |
0 |
606 |
Japan_NIID_WH-1_Seq_F519 |
548791 |
6863 |
9712 |
98.28% |
0 |
1 |
369 |
Japan_WuhanCoV-spk1 |
554212 |
4769 |
6385 |
98.87% |
1 |
1 |
594 |
Thailand_WH-NIC_N |
551265 |
11160 |
2941 |
99.48% |
0 |
2 |
375 |
Chan-N |
543747 |
15662 |
5957 |
98.95% |
4 |
3 |
353 |
Chan-ORF1ab |
9 |
558836 |
6521 |
98.85% |
0 |
5 |
2 |
Chan-S |
550675 |
5931 |
8760 |
98.45% |
5 |
0 |
2 |
Niu-E |
555439 |
6058 |
3869 |
99.32% |
26 |
359 |
0 |
Won-E |
7 |
561958 |
3401 |
99.40% |
0 |
384 |
1 |
Won-N |
548247 |
12021 |
5098 |
99.10% |
8 |
7 |
358 |
Won-ORF1ab |
557321 |
3243 |
4802 |
99.15% |
5 |
2 |
313 |
Won-S |
543572 |
3507 |
18287 |
96.77% |
5 |
1 |
0 |
Yip-ORF1ab |
554920 |
4405 |
6041 |
98.93% |
5 |
1 |
1 |
Young-N |
1 |
562014 |
3351 |
99.41% |
0 |
5 |
1 |
Young-ORF1ab |
553503 |
9608 |
2255 |
99.60% |
5 |
1 |
0 |
Young-S |
442944 |
19378 |
103044 |
81.77% |
4 |
1 |
0 |
C1_COV_ORF1a |
541039 |
8523 |
15804 |
97.20% |
0 |
0 |
0 |
C2_COV_ORF1b |
547608 |
14381 |
3377 |
99.40% |
0 |
0 |
0 |
C3_COV_ORF3a |
497339 |
51945 |
16082 |
97.16% |
0 |
0 |
0 |
C4_COV_ORF8 |
449151 |
105492 |
10723 |
98.10% |
0 |
0 |
0 |
C5_COV_S_gene |
551794 |
7443 |
6129 |
98.92% |
0 |
0 |
0 |
Updated to 612,842 COVID-19 WGS from GISAID.
Table 1. Results from PSET analysis. The five Noblis assays were compared alongside the four assays from Corman and three assays from the CDC. Along with assays from China, Hong Kong, Thailand, Japan, France, South Korea, and Singapore. Each assay was tested using SARS-CoV-2 as the intended target. All off-target hits (TN, PF, FP) are to entries in NCBI BLAST databases (nt and env_nt). *edited 2/2 to include 5 additional assays.
assay |
PT |
TP |
FN |
Percent True |
PF |
FP |
TN |
Noblis.12 |
596946 |
13235 |
2661 |
99.57% |
0 |
0 |
680 |
Noblis.40 |
602916 |
8385 |
1541 |
99.75% |
0 |
1 |
1420 |
Noblis.42 |
604096 |
5144 |
3602 |
99.41% |
0 |
2 |
1136 |
Noblis.44 |
602167 |
5733 |
4942 |
99.19% |
0 |
1 |
1786 |
Noblis.57 |
593816 |
7120 |
11906 |
98.06% |
0 |
1 |
853 |
ncov_e_gene |
606416 |
2315 |
4111 |
99.33% |
361 |
15 |
53 |
ncov_n_gene |
589936 |
17083 |
5823 |
99.05% |
0 |
340 |
72 |
ncov_rdrp_1 |
0 |
604088 |
8754 |
98.57% |
433 |
105 |
5967 |
ncov_rdrp_2 |
16 |
604437 |
8389 |
98.63% |
2 |
73 |
5916 |
cdc_n1 |
586474 |
21564 |
4804 |
99.22% |
0 |
2 |
381 |
cdc_n2 |
587540 |
18886 |
6416 |
98.95% |
0 |
1 |
372 |
cdc_n3 |
587035 |
20532 |
5275 |
99.14% |
1 |
353 |
36 |
China_N |
318368 |
45327 |
249147 |
59.35% |
0 |
2 |
691 |
China_ORF1ab |
592185 |
5331 |
15326 |
97.50% |
1 |
0 |
367 |
France_nCoV_IP2 |
600416 |
5429 |
6997 |
98.86% |
1 |
0 |
367 |
France_nCoV_IP4 |
600711 |
10173 |
1958 |
99.68% |
0 |
0 |
1190 |
HKU-N |
590470 |
15731 |
6641 |
98.92% |
327 |
33 |
34 |
HKU-ORF1b-nsp14 |
603677 |
4979 |
4186 |
99.32% |
324 |
29 |
452 |
Japan_NIID_2019-nCOV_N |
0 |
606145 |
6697 |
98.91% |
0 |
0 |
384 |
Japan_NIID_WH-1_F24381 |
595210 |
7927 |
9705 |
98.42% |
0 |
1 |
601 |
Japan_NIID_WH-1_F501 |
602499 |
6049 |
4294 |
99.30% |
0 |
1 |
370 |
Japan_NIID_WH-1_F509 |
596590 |
11765 |
4487 |
99.27% |
1 |
0 |
369 |
Japan_NIID_WH-1_Seq_F24383 |
594996 |
8081 |
9765 |
98.41% |
0 |
0 |
606 |
Japan_NIID_WH-1_Seq_F519 |
594146 |
7711 |
10985 |
98.21% |
0 |
1 |
369 |
Japan_WuhanCoV-spk1 |
597924 |
5169 |
9749 |
98.41% |
1 |
1 |
594 |
Thailand_WH-NIC_N |
595999 |
11955 |
4888 |
99.20% |
0 |
2 |
375 |
Chan-N |
588910 |
17108 |
6824 |
98.89% |
4 |
3 |
353 |
Chan-ORF1ab |
14 |
605287 |
7541 |
98.77% |
0 |
5 |
2 |
Chan-S |
596453 |
7013 |
9376 |
98.47% |
5 |
0 |
2 |
Niu-E |
601941 |
6656 |
4245 |
99.31% |
26 |
359 |
0 |
Won-E |
7 |
609067 |
3768 |
99.39% |
0 |
384 |
1 |
Won-N |
594453 |
12997 |
5392 |
99.12% |
8 |
7 |
358 |
Won-ORF1ab |
600687 |
3632 |
8523 |
98.61% |
5 |
2 |
313 |
Won-S |
589287 |
3934 |
19621 |
96.80% |
5 |
1 |
0 |
Yip-ORF1ab |
601244 |
4865 |
6733 |
98.90% |
5 |
1 |
1 |
Young-N |
1 |
607495 |
5346 |
99.13% |
0 |
5 |
1 |
Young-ORF1ab |
600138 |
10183 |
2521 |
99.59% |
5 |
1 |
0 |
Young-S |
465509 |
21589 |
125744 |
79.48% |
4 |
1 |
0 |
C1_COV_ORF1a |
586139 |
9589 |
17114 |
97.21% |
0 |
0 |
0 |
C2_COV_ORF1b |
591979 |
15595 |
5268 |
99.14% |
0 |
0 |
0 |
C3_COV_ORF3a |
534775 |
61016 |
17051 |
97.22% |
0 |
0 |
0 |
C4_COV_ORF8 |
471704 |
127922 |
13216 |
97.84% |
0 |
0 |
0 |
C5_COV_S_gene |
595102 |
8416 |
9324 |
98.48% |
0 |
0 |
0 |